P2RX7 and neurodegenerative disease: Released ATP activates P2X7 signaling, which promotes inflammatory response in neurodegenerative diseases, such as AD, amyotrophic lateral sclerosis, multiple sclerosis, and spinal cord injury that cause apoptosis or dysmorphic changes in OCs, and ultimately induces de-myelination to promote disease progression.